Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive Cash Flow -- -- Conference Call Today at 8:00 ...

Upfront cash of $25 million and milestone payments totalling up to $150 million contingent upon Recordati achieving predefined annual commercial net sales levels; Supply-based revenues, including ...

The NSE Nifty 50 was trading 1.22% higher at 25,284.45, and the BSE Sensex was trading 1.23% higher at 82,914.13 as of 11:42 ...

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a collaboration.

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

Chief Executive Antonio Filosa shuffled responsibilities within the Jeep parent company and he retained the role of head of North America and American brands. The electric-car maker launches a ...

After rejecting a buyout offer from its partner Biogen, the Cambridge firm is being acquired by Supernus Pharmaceuticals.

The company doubled its R&D expenditure to CNY 1.3 billion in 2018 from CNY 0.68 billion in 2017 after the Chinese government implemented the VBP and started cutting the prices of generic drugs ...

ImmunityBio Inc. leadership agreed to add an independent member to its board to end shareholder allegations that they caused the company to overhype Food and Drug Administration approval odds for its ...

The bill calls for coverage of all medically necessary diagnostic testing and U.S. Food & Drug Administration-approved treatments or medications to slow the progression of Alzheimer's disease or ...

People using weight loss drugs like Ozempic and Wegovy drink less 00:19. Novo Nordisk, the maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by "mutual agreement ...